Targeted Regimens and Key Takeaways for Relapse Follicular Lymphoma

Discussion on various targeted regimens available for relapse follicular lymphoma, including PI3K and EZH2 inhibitors, CAR-T agents, and a recently approved Bispecific T-cell engager. Key takeaways on identifying follicular lymphoma and indications for treatment are also provided.